Fund Universe

TCG Crossover Management, LLC

CIK 0001839948 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.740
AUM ($M)
4,161
Positions
54
Turnover
0.17
Top-10 wt
57%
Herfindahl
0.062
History (qtrs)
6
Excess Return

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 61 positions · portfolio value $4,161M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
ABVX funds › ABIVAX SA AMERICAN DEPOSITARY SHARES TRIM 19.2% -1.4% 800.6 6,007,834 -473,251 5
TNGX funds › TANGO THERAPEUTICS INC TRIM 6.8% +0.5% 283.9 9,081,201 -1,449,870 5
CGON funds › CG ONCOLOGY INC HOLD 6.3% -0.8% 260.8 3,670,206 +0 5
COGT funds › COGENT BIOSCIENCES INC TRIM 4.5% -0.9% 187.9 4,854,436 -92,458 5
IMVT funds › IMMUNOVANT INC HOLD 4.1% +1.0% 171.8 4,457,988 +0 3
SYRE funds › SPYRE THERAPEUTICS INC HOLD 4.1% +1.3% 168.7 1,900,582 +0 4
DNTH funds › DIANTHUS THERAPEUTICS INC HOLD 3.9% -0.1% 163.4 1,676,624 +0 5
MIRM funds › MIRUM PHARMACEUTICALS INC HOLD 3.0% +0.2% 124.3 1,062,049 +0 3
ZLAB funds › ZAI LAB LTD-ADR NEW 2.8% +2.8% 116.6 6,137,627 +6,137,627 1
AMLX funds › AMYLYX PHARMACEUTICALS INC HOLD 2.7% +0.2% 112.1 6,243,812 +0 5
GLUE funds › MONTE ROSA THERAPEUTICS INC HOLD 2.7% +0.5% 111.9 4,622,151 +0 3
BCRX funds › BIOCRYST PHARMACEUTICALS INC HOLD 2.6% -0.4% 110.2 11,020,968 +0 2
VOR funds › VOR BIOPHARMA INC HOLD 2.5% -0.3% 104.4 5,673,078 +0 2
TYRA funds › TYRA BIOSCIENCES INC HOLD 2.5% -1.1% 103.8 3,248,980 +0 5
DYN funds › DYNE THERAPEUTICS INC HOLD 2.5% +0.1% 102.5 4,615,144 +0 5
IRON funds › DISC MEDICINE INC HOLD 2.4% -0.1% 98.1 1,341,862 +0 2
RLAY funds › RELAY THERAPEUTICS INC HOLD 1.9% +0.7% 80.0 4,273,356 +0 4
SVRA funds › SAVARA INC HOLD 1.8% -0.1% 76.2 12,362,205 +0 5
AURA funds › AURA BIOSCIENCES INC NEW 1.6% +1.6% 67.7 9,533,333 +9,533,333 1
RVMD funds › REVOLUTION MEDICINES INC TRIM 1.5% -0.1% 63.8 340,899 -235,574 4
TRAX funds › FIRST TRACKS BIOTHERAPEUTICS NEW 1.4% +1.4% 58.3 2,895,304 +2,895,304 1
KOD funds › KODIAK SCIENCES INC HOLD 1.4% -0.2% 56.3 1,445,538 +0 5
AVTX funds › AVALO THERAPEUTICS INC ADD 1.3% +1.0% 55.8 3,017,120 +2,278,737 5
LBRX funds › LB PHARMACEUTICALS INC TRIM 1.1% -0.2% 47.0 1,447,310 -392,179 4
IPSC funds › CENTURY THERAPEUTICS INC HOLD 1.0% -0.1% 43.4 17,754,430 +0 2
TECX funds › TECTONIC THERAPEUTIC INC HOLD 1.0% -0.1% 41.4 1,204,891 +0 2
XNCR funds › XENCOR INC HOLD 0.9% +0.1% 39.5 2,452,138 +0 5
SRZN funds › SURROZEN INC HOLD 0.9% -0.3% 38.2 1,473,101 +0 2
EDIT funds › EDITAS MEDICINE INC NEW 0.9% +0.9% 36.0 11,111,111 +11,111,111 1
MBX funds › MBX BIOSCIENCES INC HOLD 0.9% +0.3% 35.9 650,000 +0 5
PHVS funds › PHARVARIS BV NEW 0.8% +0.8% 34.9 1,008,229 +1,008,229 1
SLN funds › SILENCE THERAPEUTICS PLC HOLD 0.8% +0.3% 33.3 3,033,560 +0 5
IFRX funds › INFLARX N V NEW 0.8% +0.8% 32.5 14,500,000 +14,500,000 1
ALT funds › ALTIMMUNE INC NEW 0.7% +0.7% 30.4 10,000,000 +10,000,000 1
JANX funds › JANUX THERAPEUTICS INC HOLD 0.7% -0.1% 27.5 1,789,617 +0 3
CATX funds › PERSPECTIVE THERAPEUTICS INC HOLD 0.6% -0.3% 27.0 7,915,567 +0 2
AGMB funds › AGOMAB THERAPEUTICS NV HOLD 0.6% +0.0% 26.7 2,053,233 +0 2
BHVN funds › BIOHAVEN LTD TRIM 0.6% -0.5% 26.5 1,779,952 -2,851,365 3
AKTS funds › AKTIS ONCOLOGY INC NEW 0.5% +0.5% 22.5 696,560 +696,560 1
ALEC funds › ALECTOR INC HOLD 0.5% -0.1% 20.1 10,000,000 +0 3
FBRX funds › FORTE BIOSCIENCES INC NEW 0.5% +0.5% 19.6 920,000 +920,000 1
MNPR funds › MONOPAR THERAPEUTICS INC ADD 0.5% +0.2% 18.8 203,327 +71,224 4
OCUL funds › OCULAR THERAPEUTIX INC HOLD 0.4% -0.0% 16.2 1,647,752 +0 5
ADCT funds › ADC THERAPEUTICS SA HOLD 0.3% -0.9% 12.2 11,390,175 +0 4
ALXO funds › ALX ONCOLOGY HOLDINGS INC TRIM Common Stock 0.3% -0.5% 11.7 5,655,487 -7,356,362 2
TRDA funds › ENTRADA THERAPEUTICS INC TRIM 0.2% -0.6% 7.8 1,060,230 -1,227,270 5
CGEM funds › CULLINAN THERAPEUTICS INC HOLD 0.2% +0.0% 7.4 406,786 +0 2
ARVN funds › ARVINAS HOLDING CO LLC TRIM 0.1% -0.6% 5.9 707,098 -1,680,363 4
KRRO funds › KORRO BIO INC HOLD 0.1% -0.0% 5.5 416,301 +0 4
RACC funds › RESEARCH ALLIANCE CORP CL A NEW 0.1% +0.1% 5.3 500,000 +500,000 1
LONA funds › LEONABIO INC HOLD 0.1% -0.0% 4.3 464,398 +0 3
JATT funds › JATT II ACQUISITION CORP NEW 0.1% +0.1% 2.3 200,000 +200,000 1
CNTX funds › CONTEXT THERAPEUTICS INC HOLD 0.0% -0.2% 1.5 2,682,696 +0 2
EIKN funds › EIKON THERAPEUTICS INC NEW 0.0% +0.0% 0.5 37,902 +37,902 1
URGN funds › UROGEN PHARMA LTD EXIT 0.0% -0.2% 0.0 0 -405,365 0
CUSIP:152309100 funds › CENTESSA PHARMACEUTICALS PLC EXIT 0.0% -4.9% 0.0 0 -4,286,480 0
UPB funds › UPSTREAM BIO INC EXIT 0.0% -0.0% 0.0 0 -181,063 0
GPCR funds › STRUCTURE THERAPEUTICS INC EXIT 0.0% -0.2% 0.0 0 -140,411 0
FULC funds › FULCRUM THERAPEUTICS INC EXIT 0.0% -1.2% 0.0 0 -5,250,000 0
VTGN funds › VISTAGEN THERAPEUTICS INC EXIT 0.0% -0.0% 0.0 0 -2,676,580 0
LQDA funds › LIQUIDIA TECHNOLOGIES INC EXIT 0.0% -0.4% 0.0 0 -403,048 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 4,161 54 0.17 57% 0.062 0.737 in
2026Q1 3,495 49 0.29 61% 0.069 0.527 in
2025Q4 3,022 43 0.18 64% 0.120 0.694 in
2025Q3 2,033 40 0.35 66% 0.110 0.320 in
2025Q2 876 38 0.21 56% 0.046 0.423 entered
2025Q1 733 38 0.00 55% 0.046 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status